» Viva Biotech's Wholly-Owned Subsidiary Langhua Pharmaceutical Successfully Passes U.S. FDA On-Site Inspection

By:
On:
In: Business
With: 0 Comments




Viva Biotech's Wholly-Owned Subsidiary Langhua Pharmaceutical Successfully Passes U.S. FDA On-Site Inspection



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *